MX2020003706A - Aminoimidazopiridazinas como inhibidores de cinasa. - Google Patents
Aminoimidazopiridazinas como inhibidores de cinasa.Info
- Publication number
- MX2020003706A MX2020003706A MX2020003706A MX2020003706A MX2020003706A MX 2020003706 A MX2020003706 A MX 2020003706A MX 2020003706 A MX2020003706 A MX 2020003706A MX 2020003706 A MX2020003706 A MX 2020003706A MX 2020003706 A MX2020003706 A MX 2020003706A
- Authority
- MX
- Mexico
- Prior art keywords
- aminoimidazopyridazines
- kinase inhibitors
- kinase
- inhibitors
- empty
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Abstract
La presente invención se refiere a compuestos que tienen la fórmula (I), y enantiómeros, y diastereómeros, estereoisómreos, sales de los mismos farmacéuticamente aceptables, (ver fórmula I) son útiles como inhibidores de cinasa, que incluyen modulación de RIPK1. Todas las variables son como se definen en la presente.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762578607P | 2017-10-30 | 2017-10-30 | |
US201862626853P | 2018-02-06 | 2018-02-06 | |
PCT/US2018/057968 WO2019089442A1 (en) | 2017-10-30 | 2018-10-29 | Aminoimidazopyridines as kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020003706A true MX2020003706A (es) | 2020-07-22 |
Family
ID=64332173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020003706A MX2020003706A (es) | 2017-10-30 | 2018-10-29 | Aminoimidazopiridazinas como inhibidores de cinasa. |
Country Status (21)
Country | Link |
---|---|
US (1) | US11440913B2 (es) |
EP (1) | EP3704118B1 (es) |
JP (1) | JP7228586B2 (es) |
CN (1) | CN111566103B (es) |
AU (1) | AU2018361249B2 (es) |
BR (1) | BR112020007557A2 (es) |
CA (1) | CA3080402A1 (es) |
CY (1) | CY1124984T1 (es) |
DK (1) | DK3704118T3 (es) |
ES (1) | ES2905948T3 (es) |
HR (1) | HRP20220297T1 (es) |
HU (1) | HUE058292T2 (es) |
IL (1) | IL274207B2 (es) |
LT (1) | LT3704118T (es) |
MX (1) | MX2020003706A (es) |
PL (1) | PL3704118T3 (es) |
PT (1) | PT3704118T (es) |
RS (1) | RS62974B1 (es) |
SG (1) | SG11202003824PA (es) |
SI (1) | SI3704118T1 (es) |
WO (1) | WO2019089442A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3580220T1 (sl) | 2017-02-13 | 2022-01-31 | Bristol-Myers Squibb Company | Aminotriazolopiridini kot kinazni inhibitorji |
EP3743430B1 (en) | 2018-01-26 | 2023-08-02 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
CA3153083A1 (en) * | 2019-10-03 | 2021-04-08 | Jie Chen | Indazole carboxamides as kinase inhibitors |
WO2021168521A1 (en) * | 2020-02-27 | 2021-09-02 | Anaxis Pharma Pty Ltd | Inhibitors of necroptosis |
CA3193415A1 (en) * | 2020-10-13 | 2022-04-21 | The Johns Hopkins University | Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof |
AR123793A1 (es) * | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070978A1 (es) | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
PE20091268A1 (es) * | 2007-12-19 | 2009-09-19 | Amgen Inc | Derivados heterociclicos como inhibidores de pi3 quinasa |
EP2393813B1 (en) * | 2009-02-04 | 2013-07-31 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 ß-hydroxysteroid dehydrogenase 1 useful for the treatment of diseases related to elevated level of cortisol |
BR112014030147B1 (pt) | 2012-06-22 | 2019-10-15 | Sumitomo Chemical Company, Limited | Compostos heterocíclicos fundidos, composição e método para controlar pestes |
WO2014047024A1 (en) | 2012-09-18 | 2014-03-27 | Bristol-Myers Squibb Company | Iap antagonists |
US9771326B2 (en) | 2012-11-20 | 2017-09-26 | Biogen Ma Inc. | S1P and/or ATX modulating agents |
EP2970266B1 (en) | 2013-03-15 | 2018-01-31 | Epizyme, Inc. | 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof |
BR112015030774A2 (pt) | 2013-06-10 | 2017-07-25 | Bayer Pharma AG | novos compostos para o tratamento de câncer |
EP3182974A1 (en) | 2014-08-21 | 2017-06-28 | GlaxoSmithKline Intellectual Property Development Limited | Heterocyclic amides as rip1 kinase inhibitors as medicaments |
EP3452481A4 (en) | 2016-05-05 | 2020-02-26 | Lysosomal Therapeutics Inc. | IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS |
WO2018017435A1 (en) | 2016-07-22 | 2018-01-25 | Accro Bioscience Inc. | Heteroaryl compounds as inhibitors of necrosis, composition and application thereof |
SI3580220T1 (sl) | 2017-02-13 | 2022-01-31 | Bristol-Myers Squibb Company | Aminotriazolopiridini kot kinazni inhibitorji |
EP3743430B1 (en) | 2018-01-26 | 2023-08-02 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
CN112673000A (zh) | 2018-09-13 | 2021-04-16 | 百时美施贵宝公司 | 作为受体相互作用蛋白激酶1抑制剂(ripk1)的1h-吲唑甲酰胺 |
KR20210060516A (ko) | 2018-09-13 | 2021-05-26 | 브리스톨-마이어스 스큅 컴퍼니 | 키나제 억제제로서의 인다졸 카르복스아미드 |
US20230391768A2 (en) * | 2018-11-07 | 2023-12-07 | Dana-Farber Cancer Institute, Inc. | Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof |
-
2018
- 2018-10-29 SI SI201830556T patent/SI3704118T1/sl unknown
- 2018-10-29 US US16/758,892 patent/US11440913B2/en active Active
- 2018-10-29 BR BR112020007557-4A patent/BR112020007557A2/pt unknown
- 2018-10-29 ES ES18804177T patent/ES2905948T3/es active Active
- 2018-10-29 SG SG11202003824PA patent/SG11202003824PA/en unknown
- 2018-10-29 HR HRP20220297TT patent/HRP20220297T1/hr unknown
- 2018-10-29 CA CA3080402A patent/CA3080402A1/en active Pending
- 2018-10-29 MX MX2020003706A patent/MX2020003706A/es unknown
- 2018-10-29 CN CN201880084047.7A patent/CN111566103B/zh active Active
- 2018-10-29 PL PL18804177T patent/PL3704118T3/pl unknown
- 2018-10-29 LT LTEPPCT/US2018/057968T patent/LT3704118T/lt unknown
- 2018-10-29 AU AU2018361249A patent/AU2018361249B2/en active Active
- 2018-10-29 DK DK18804177.6T patent/DK3704118T3/da active
- 2018-10-29 EP EP18804177.6A patent/EP3704118B1/en active Active
- 2018-10-29 HU HUE18804177A patent/HUE058292T2/hu unknown
- 2018-10-29 RS RS20220215A patent/RS62974B1/sr unknown
- 2018-10-29 WO PCT/US2018/057968 patent/WO2019089442A1/en unknown
- 2018-10-29 PT PT188041776T patent/PT3704118T/pt unknown
- 2018-10-29 JP JP2020524156A patent/JP7228586B2/ja active Active
-
2020
- 2020-04-24 IL IL274207A patent/IL274207B2/en unknown
-
2022
- 2022-03-08 CY CY20221100117T patent/CY1124984T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1124984T1 (el) | 2023-01-05 |
DK3704118T3 (da) | 2022-03-14 |
EP3704118A1 (en) | 2020-09-09 |
IL274207B (en) | 2022-12-01 |
IL274207A (en) | 2020-06-30 |
EP3704118B1 (en) | 2022-01-12 |
WO2019089442A8 (en) | 2019-06-27 |
WO2019089442A1 (en) | 2019-05-09 |
JP2021501179A (ja) | 2021-01-14 |
IL274207B2 (en) | 2023-04-01 |
BR112020007557A2 (pt) | 2020-09-24 |
AU2018361249B2 (en) | 2022-08-25 |
JP7228586B2 (ja) | 2023-02-24 |
ES2905948T3 (es) | 2022-04-12 |
CA3080402A1 (en) | 2019-05-09 |
RS62974B1 (sr) | 2022-03-31 |
CN111566103A (zh) | 2020-08-21 |
SG11202003824PA (en) | 2020-05-28 |
CN111566103B (zh) | 2023-06-23 |
HRP20220297T1 (hr) | 2022-05-13 |
US20200277296A1 (en) | 2020-09-03 |
SI3704118T1 (sl) | 2022-04-29 |
PL3704118T3 (pl) | 2022-04-04 |
PT3704118T (pt) | 2022-02-14 |
US11440913B2 (en) | 2022-09-13 |
LT3704118T (lt) | 2022-02-25 |
AU2018361249A1 (en) | 2020-06-11 |
HUE058292T2 (hu) | 2022-07-28 |
KR20200078591A (ko) | 2020-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020004084A (es) | Agentes farmaceuticos como inhibidores del rsv para utilizar en combinacion. | |
GEP20217234B (en) | Pyridopyrimdinone cdk2/4/6 inhibitors | |
MX2020004287A (es) | Procesamiento de biomasa. | |
MX2020003421A (es) | Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2). | |
MX2020003430A (es) | Derivados de 1-bencil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de proteasa de virus de inmunodeficiencia humana. | |
IL268614A (en) | Aminotriazolopyridines as kinase inhibitors | |
MX2017000363A (es) | Inhibicion de la via de notch. | |
MX2020004255A (es) | Compuesto de pirimidina como inhibidor de las janocinasas. | |
IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
MX2020003706A (es) | Aminoimidazopiridazinas como inhibidores de cinasa. | |
MX2020003760A (es) | Formulaciones de niraparib. | |
MX2020003712A (es) | Union giratoria de pasaje multiple. | |
MX2020004455A (es) | Derivados de pirrolopirazina como inhibidores de integrina alfa v. | |
MX2020004424A (es) | Formulacion aerosolizable. | |
MX2020003439A (es) | Compuestos biciclicos para usarse como inhibidores de cinasa de la proteina 1 de interaccion con receptores (rip1). | |
MX2020004245A (es) | Estabilizador mejorado para poliamidas. | |
MX2020002908A (es) | Composicion acuosa de polimeros. | |
MX2020003611A (es) | Metodos de refuerzo del pozo. | |
MX2020004048A (es) | Formas cristalinas de lenalidomida. | |
MX2020004422A (es) | Formulacion vaporizable saborizada. | |
MX2020003440A (es) | Red de seguridad. | |
GB201807845D0 (en) | Kinase Inhibitors | |
MX2020003487A (es) | Compuestos inhibidores de pirimidina tbk/ikkepsilon y usos de los mismos. | |
MX2020003703A (es) | Composiciones de sabor. | |
MX2020004664A (es) | Dispositivo generador de humo mejorado. |